Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron A. Jacobson, +28

New England Journal of Medicine

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro, Ranjana H. Advani, Pauline Brice, +11

Journal of Clinical Oncology

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Eileen M. O’Reilly, Do‐Youn Oh, Neesha C. Dhani, +11

JAMA Oncology

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Caron A. Jacobson, Julio C. Chávez, Alison R. Sehgal, +20

The Lancet Oncology

Lymphoid NeoplasiaAxicabtagene CiloleucelMedicinePathologyPharmacotherapy +6

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten, +27

New England Journal of Medicine

Functional mechanism

Jun Zhang, Zhenjie Zhang, Xiaokui Xiao, +2

Proceedings of the VLDB Endowment

Privacy PreservationPrivacy Complianceε-Differential PrivacyPrivacy ProtectionEngineering +13

Heavy Hitter Estimation over Set-Valued Data with Local Differential Privacy

Zhan Qin, Yin Yang, Ting Yu, +3

Privacy ProtectionEngineeringData CollectorData ScienceData Mining +18

Differentially private histogram publication

Jia Xu, Zhenjie Zhang, Xiaokui Xiao, +3

The VLDB Journal

Private Histogram PublicationPrivacy ProtectionEngineeringData ScienceInformation Security +7

Generating Synthetic Decentralized Social Graphs with Local Differential Privacy

Zhan Qin, Ting Yu, Yin Yang, +3

EngineeringNetwork AnalysisCommunicationSocial NetworkComputational Social Science +19

Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women

Thomas R. Hawn, Delia Scholes, Shuying S. Li, +9

PLoS ONE